Study of the ELIOS Laser Device for Combined Cataract and Glaucoma Surgery to Lower Eye Pressure Safely and Effectively

What this Trial Is About

Glaucoma is an irreversible optic nerve disease and the second leading cause of blindness worldwide. It can be treated with eye drops, laser, or surgery. Traditional surgery is invasive and carries risks such as hypotonia, infections, and cataracts. To reduce these risks, micro-invasive glaucoma surgeries MIGS have been developed, including the ELIOS laser system, which is specifically designed to treat glaucoma by creating tiny channels in the eyes drainage system to lower intraocular pressure IOP. This study aims to collect data on the effectiveness and safety of the ELIOS laser in combination with cataract surgery to improve patient care. Participants will undergo combined cataract and glaucoma surgery using the ELIOS laser. During the procedure, the surgeon uses the laser probe to create 10 microchannels about 210 micrometers in diameter in the trabecular meshwork and Schlemms canal to enhance fluid drainage from the eye. This micro-invasive laser procedure is performed alongside standard cataract surgery phacoemulsification and typically takes only a few minutes. The ELIOS laser is already in use in France and this study will gather prospective data on its use. Participants will be monitored regularly after surgery with measurements of intraocular pressure on day 0, day 7, day 30, and at 3, 6, and 12 months. Researchers will also assess quality of life before surgery and at 1, 3, 6, and 12 months afterward. The study will track safety and effectiveness over this one-year period to better understand outcomes for glaucoma patients receiving this combined surgery.

Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery